Global HIV/AIDS Clinical and Translational Pharmacology
- PMID: 22852073
- PMCID: PMC3407604
- DOI: 10.1155/2012/973627
Global HIV/AIDS Clinical and Translational Pharmacology
Similar articles
-
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial.Clin Transl Sci. 2021 May;14(3):1069-1081. doi: 10.1111/cts.12972. Epub 2021 Feb 2. Clin Transl Sci. 2021. PMID: 33503305 Free PMC article. Clinical Trial.
-
Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.J Immunol Methods. 2014 Jul;409:1-5. doi: 10.1016/j.jim.2014.05.016. Epub 2014 Jun 6. J Immunol Methods. 2014. PMID: 24910413 Free PMC article.
-
The burden of HIV: insights from the Global Burden of Disease Study 2010.AIDS. 2013 Aug 24;27(13):2003-17. doi: 10.1097/QAD.0b013e328362ba67. AIDS. 2013. PMID: 23660576 Free PMC article.
-
Ending the HIV/AIDS Pandemic1.Emerg Infect Dis. 2018 Mar;24(3):413-416. doi: 10.3201/eid2403.171797. Emerg Infect Dis. 2018. PMID: 29460740 Free PMC article. Review.
-
Global partnerships to support noncommunicable disease care in low and middle-income countries: lessons from HIV/AIDS.AIDS. 2018 Jul 1;32 Suppl 1:S75-S82. doi: 10.1097/QAD.0000000000001880. AIDS. 2018. PMID: 29952793
Cited by
-
Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.Clin Infect Dis. 2021 May 18;72(10):1823-1825. doi: 10.1093/cid/ciaa982. Clin Infect Dis. 2021. PMID: 32667998 Free PMC article. No abstract available.
-
Clinical pharmacology quality assurance for HIV and related infectious diseases research.Clin Pharmacol Ther. 2013 Jun;93(6):479-82. doi: 10.1038/clpt.2013.62. Epub 2013 Mar 26. Clin Pharmacol Ther. 2013. PMID: 23588323 Free PMC article. No abstract available.
References
-
- Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. Journal of Infectious Diseases. 2008;198(1):59–67. - PubMed
-
- Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. The Lancet. 2006;368(9534):531–536. - PubMed
-
- Wood E, Montaner JSG, Bangsberg DR, et al. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS. 2003;17(17):2419–2427. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources